MCO
64
8
ECL
49
4
GOOGL
45
2
CTAS
45
5
GRMN
48
2
NRG
60
6
IBM
57
2
PSA
60
2
AA
45
2
MHK
42
-6
BXP
38
4
F
55
3
AMP
66
3
JCI
45
4
MTCH
48
4
OMC
55
2
PCG
61
5
NUE
47
3
DIS
69
15
KSS
23
2
MCO
64
8
ECL
49
4
GOOGL
45
2
CTAS
45
5
GRMN
48
2
NRG
60
6
IBM
57
2
PSA
60
2
AA
45
2
MHK
42
-6
BXP
38
4
F
55
3
AMP
66
3
JCI
45
4
MTCH
48
4
OMC
55
2
PCG
61
5
NUE
47
3
DIS
69
15
KSS
23
2
Financhill
Back

Gilead Sciences 10K Form

Buy
63

GILD
Gilead Sciences

Last Price:
$111.45
Seasonality Move:
2.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q GILD/Gilead Sciences Quarterly
2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $28.8B
Cash Flow: $2.8B
Price / Cash Flow: 13.6
Annual Sales: $15.51
Price / Book: 7.18

Profitability

EPS (TTM): 0.37000
Net Income (TTM): $480M
Gross Margin: $22.5B
Return on Equity: 2.5%
Return on Assets: 0.84%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 34 years for GILD is 78.26%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 21.18% of Gross Profit Margin.
  • The Research & Development expenses have been 20.54% of Revenue.
  • The Interest Expense is 203.54% of Operating Income.
  • The Net Earning history of GILD is 1.67% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 21 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 1.38
Current Ratio: 1.6
Quick Ratio: 1.33

Price-to-Earnings

Trailing P/E Ratio: 293.26
Forward P/E Ratio: 13.37

GILD Technical Analysis vs Fundamental Analysis

Buy
63
Gilead Sciences (GILD) is a Buy

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Buy
    The current Gilead Sciences [GILD] share price is $111.44. The Score for GILD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.